SuperworthUsana Health Sciences shares outstanding USNA
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jul 4, 2026
- 18.5M
- On a year earlier
- −0.3%
- fewer shares
Usana Health Sciences had 18.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jul 4, 2026.
That is about the same as a year earlier.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 18.3M | −4% |
| FY2024 | 19.1M | −1% |
| FY2023 | 19.3M | −0% |
| FY2022 | 19.3M | −2% |
| FY2021 | 19.7M | −7% |
| FY2020 | 21.2M | −3% |
| FY2019 | 21.8M | −11% |
| FY2018 | 24.5M | +2% |
| FY2017 | 24M | −4% |
| FY2016 | 25M | −4% |
| FY2015 | 26.2M | +1% |
| FY2014 | 25.8M | −10% |
| FY2013 | 28.8M | −1% |
| FY2012 | 29M | −4% |
| FY2011 | 30.3M | −8% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 18.5M | −0% | |
| Q1 FY26 | 18.4M | −4% | |
| Q4 FY25 | 18.3M | −4% | |
| Q3 FY25 | 18.3M | −4% | |
| Q2 FY25 | 18.5M | −3% | |
| Q1 FY25 | 19.1M | −1% | |
| Q4 FY24 | 19.1M | −1% | |
| Q3 FY24 | 19.1M | −1% | |
| Q2 FY24 | 19.2M | −1% | |
| Q1 FY24 | 19.3M | −0% | |
| Q4 FY23 | 19.3M | −0% | |
| Q3 FY23 | 19.4M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Usana Health Sciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.